| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/18/2006 | CN1237176C Method for remodelling cell wall polysaccharide structures in plants |
| 01/18/2006 | CN1237076C Polypeptide variants with altered effector function |
| 01/18/2006 | CN1237062C Ortho-substituted anthranilic acid amides and their use as medicaments |
| 01/18/2006 | CN1237061C Chemokine receptor binding heterocyclic compounds |
| 01/18/2006 | CN1236818C Caprine arthritis-encephalitis virus provided immunoprotection against HIV-1 infection |
| 01/18/2006 | CN1236813C Self-emulsifying compositions for drugs poorly soluble in water |
| 01/18/2006 | CA2572427A1 Immuno stimulating complex and oligonucleotide formulations for inducing enhanced interferon-gamma responses |
| 01/17/2006 | US6987176 Combinant polypeptide for use in the manufacture of vaccines against Campylobacter induced diarrhea and to reduce colonization |
| 01/17/2006 | US6987171 Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes |
| 01/17/2006 | US6987168 Tryptase inhibitor proteins derived from blood-feeding anthropod ectoparasites |
| 01/17/2006 | US6987110 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 01/17/2006 | US6987102 Methods to mobilize progenitor/stem cells |
| 01/17/2006 | US6987088 Novel compounds which bind to the human erbB2 gene product (ErbB2, also known as HER2, or c-ErbB-2). In particular aspects, the invention provides for the treatment of disorders characterized by the overexpression of ErbB2 utilizing the |
| 01/17/2006 | US6987005 Where the human SNORF33 receptor has the amino acid sequence SEQ ID NO: 6; encoded by ATCC deposited plasmids; activated by either tyramine, tryptamine, or beta -phenyl-ethylamine; vectors; cells; membranes; nervous system disorders |
| 01/17/2006 | US6986996 Using anti-heparanase antibody to bind heparanase encoded by amino acid sequence no.1 for monitoring heparanase protein expression of heparanase gene in white blood cells in vitro; drug delivery targets; diagnosis of tumors, cancer and metastasis |
| 01/17/2006 | US6986990 Pollen allergy-related gene 513 |
| 01/17/2006 | US6986904 Formulation |
| 01/17/2006 | US6986900 biocompatible implants for delivery of pharmaceutically active agents to the posterior segment of the eye; having a scleral surface, an orbital surface, an injection port on the orbital surface, and a fluid conducting passageway |
| 01/17/2006 | US6986891 Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof |
| 01/17/2006 | US6986889 Complexing; removal from blood circulation |
| 01/17/2006 | US6986346 Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage |
| 01/17/2006 | CA2177171C Novel substituted oxazolidines |
| 01/12/2006 | US20060009528 Cannabinoid receptor ligands |
| 01/12/2006 | US20060009527 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009526 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009525 Hydroxamic acids and acyl hydroxamines as NAALADase inhibitors |
| 01/12/2006 | US20060009482 Screening method for identifying compounds that selectively induce interferon alpha |
| 01/12/2006 | US20060009438 Administering steroid (such as estrogen) containing hydrophobic substitutions such as adamantane ring; therapy for Alzheimer's, Parkinson's, huntington's disease; multiple sclerosis; amyotrophic lateral sclerosis; strokes; antiischemic agents |
| 01/12/2006 | US20060009409 Double-stranded oligonucleotides |
| 01/12/2006 | US20060009402 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes |
| 01/12/2006 | US20060009385 Multiple-variable dose regimen for treating TNFalpha-related disorders |
| 01/12/2006 | US20060008889 Phosphatase specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative, autoimmune, muscular and graft vs. host diseases |
| 01/12/2006 | US20060008882 Antibody or fragment that specifically binds to CK alpha -5 polypeptides; may be chimeric antibody or fragment thereof, a single chain antibody, a Fab fragment, or a F(ab')2 fragment; Western blot or an enzyme-linked immunosorbent assay; hybridoma that produces the antibody |
| 01/12/2006 | US20060008873 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 01/12/2006 | US20060008478 Immunoadjuvant |
| 01/12/2006 | US20060008471 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus |
| 01/12/2006 | US20060008465 Novel methods for therapeutic vaccination |
| 01/12/2006 | US20060008460 Inhibits B-cell activation by binding to protein receptor on helper T-cell membrane; treatment of allergy or autoimmune disease |
| 01/12/2006 | DE19961182B4 Galactomannan-Oligosaccharide und Verfahren zu deren Herstellung sowie deren Verwendung Galactomannan oligosaccharides and processes for their preparation and their use |
| 01/12/2006 | CA2572316A1 Imidazolo-related compounds, compositions and methods for their use |
| 01/12/2006 | CA2572310A1 Sphingolipid-derived pharmaceutical compositions |
| 01/12/2006 | CA2572084A1 Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use |
| 01/12/2006 | CA2572083A1 Fused pyrimidine derivatives and compositions thereof as cxcr3 receptor modulators, useful in prevention and treatment of inflammatory and immunoregulatory disorders and diseases |
| 01/12/2006 | CA2571799A1 Anti-il-13 immunoglobulins |
| 01/12/2006 | CA2571440A1 Use of steroid-derived pharmaceutical compositions for treating disorders relating to pathological processes in lipid rafts |
| 01/12/2006 | CA2571035A1 Compositions and methods for treating neurological disorders |
| 01/12/2006 | CA2569530A1 Thienopyrazole derivative having pde 7 inhibitory activity |
| 01/11/2006 | EP1614689A1 Benzoxepino-11-piperidylidene compounds and process for production thereof |
| 01/11/2006 | EP1614426A1 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
| 01/11/2006 | EP1614421A2 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
| 01/11/2006 | EP1613628A2 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 01/11/2006 | EP1613588A2 2-propylidene-19-nor-vitamin d compounds |
| 01/11/2006 | EP1613554A1 Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry |
| 01/11/2006 | EP1613336A1 Histamine binding compounds for treatment method for disease conditions mediated by neutrophils |
| 01/11/2006 | EP1613310A1 Imidazole derivatives for treatment of allergic and hyperproliferative disorders |
| 01/11/2006 | EP1613288A1 Solid pharmaceutical compositions comprising a s1p receptor agonist and a sugar alcohol |
| 01/11/2006 | EP1613273A2 Recombinant il-9 antibodies and uses thereof |
| 01/11/2006 | EP1442036B1 Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1 |
| 01/11/2006 | EP1435986A4 Igf-binding protein-derived peptide or small molecule |
| 01/11/2006 | EP1421082B1 piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 01/11/2006 | EP1414481B1 Use of cetrorelix for the treatment of jacob-creutzfeldt-disease |
| 01/11/2006 | EP1366036B1 Compounds having activity as inhibitors of cytochrome p450rai |
| 01/11/2006 | EP1303540B1 Multi-specific reagent for selective stimulation of cell surface receptors |
| 01/11/2006 | EP1294924B1 Competitive assay for identifying allosteric inhibitors |
| 01/11/2006 | EP1127064B1 Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 01/11/2006 | EP1104306B1 Compositions of cpg and saponin adjuvants and methods of use thereof |
| 01/11/2006 | EP1073749B1 Enhancing immune responses to genetic immunization by using a chemokine |
| 01/11/2006 | EP1037632B1 Benzothiazole protein tyrosine kinase inhibitors |
| 01/11/2006 | EP0946557B1 A-1-adenosine receptor antagonists |
| 01/11/2006 | EP0823913B1 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof |
| 01/11/2006 | EP0821692B1 Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 01/11/2006 | EP0766569B1 Aav capsid vehicles for molecular transfer |
| 01/11/2006 | CN1720326A Method of strengthening foreign epitope presentation by MHC class I by inhibiting TAP activity |
| 01/11/2006 | CN1720038A Gabapentin analogues for fibromy algia and other disorders |
| 01/11/2006 | CN1720029A Alpha-2-delta ligand to treat lower urinary tract symptoms |
| 01/11/2006 | CN1718590A Poria cocos mycellium glucan sulphate derivative and its preparation method and use |
| 01/11/2006 | CN1718573A Heterocyclic compound |
| 01/11/2006 | CN1718240A Use of recombinant human interferon omega for treating anaphylactic rhinitis |
| 01/11/2006 | CN1718208A Health-care medicinal liquor, and its prepn. method |
| 01/11/2006 | CN1236067C Preparation process of rise bran polysaccharose kind active component |
| 01/11/2006 | CN1235911C Multiple cytokine-antibody complexes |
| 01/11/2006 | CN1235900C Thioether substituted imidazoquinolines |
| 01/11/2006 | CN1235875C Substituted alpha hydroxy acid aspertate specific cysteine protease inhibitors and use thereof |
| 01/11/2006 | CN1235640C Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 01/11/2006 | CN1235594C Cell growth regulating factor Q and its prepn process |
| 01/11/2006 | CN1235593C Regulatory factor T for cell growth, and its prepn. method |
| 01/11/2006 | CN1235589C Use of type 4 phosphodiesterase inhibitors in myocardial diseases |
| 01/11/2006 | CN1235578C Fumaric acid microtablets |
| 01/11/2006 | CN1235575C Coenzyme Q10 aseptic free-drying preparation for injection and its preparing method |
| 01/11/2006 | CN1235568C Aqueous-based pharmaceutical composition |
| 01/10/2006 | US6984721 Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins GP300, P200, and P90/80 |
| 01/10/2006 | US6984720 cytotoxic t lymphocytes; immunology |
| 01/10/2006 | US6984657 Indole derivatives as MCP-1 receptor antagonists |
| 01/10/2006 | US6984651 Piperidine amides as modulators of chemokine receptor activity |
| 01/10/2006 | US6984649 Pyridine derivatives |
| 01/10/2006 | US6984648 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 01/10/2006 | US6984639 such as (2S)-3,3-dimethyl-1-[2-(5-phenylpentanoyl) pyrrolidinyl]pentane-1,2-dione which has affinity for immunophilin; for treatment of neurological disorders/neurodegenerative diseases; nerve growth factors; FK binding proteins |
| 01/10/2006 | US6984637 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 01/10/2006 | US6984636 Mitochondrially targeted antioxidants |
| 01/10/2006 | US6984635 Dimerizing agents, their production and use |